Evidence map›Paper›PMID 36964864›Full record

ArticleFunctional & integrative genomics2023

Amazon Biobank: a collaborative genetic database for bioeconomy development.

Leonardo T Kimura, Ewerton R Andrade, Ismael Nobre, Carlos A Nobre, Bruno A S de Medeiros, Diego M Riaño-Pachón, Felipe K Shiraishi, Tereza C M B Carvalho, Marcos A Simplicio

Abstract read
PubMed Publisher
In one paragraph

Article in Functional & integrative genomics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Exploration of carotenoid-producingCurrent research in microbial sciences · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Leonardo T KimuraUniversity of Sao Paulo, Sao Paulo, SP, Brazil.
Ewerton R AndradeUniversity of Sao Paulo, Sao Paulo, SP, Brazil.
Ismael NobreAmazon 4.0 Institute, Manaus, AM, Brazil.
Carlos A NobreAmazon 4.0 Institute, Manaus, AM, Brazil.
Bruno A S de MedeirosField Museum, Chicago, IL, USA.
Diego M Riaño-PachónUniversity of Sao Paulo, Sao Paulo, SP, Brazil.
Felipe K ShiraishiUniversity of Sao Paulo, Sao Paulo, SP, Brazil.
Tereza C M B CarvalhoUniversity of Sao Paulo, Sao Paulo, SP, Brazil.
Marcos A SimplicioUniversity of Sao Paulo, Sao Paulo, SP, Brazil. mjunior@larc.usp.br.

Funding

Conselho Nacional de Desenvolvimento Científico e Tecnológico 304643/2020-3Conselho Nacional de Desenvolvimento Científico e Tecnológico 310080/2018-5
6 · The paper itself

Abstract

Biodiversity is proposed as a sustainable alternative for the economic development of high-biodiversity regions. Especially in the field of biodiversity genomics, the development of low-cost DNA sequencing opens an opportunity for new actors beyond academia to engage in genomic sequencing. However, it is challenging to adequately compensate non-academic actors such as local populations for their contribution to the innovation process, preventing better bioeconomy development. Although many repositories register genomic data to support biodiversity research, they do not facilitate the fair sharing of economic benefits. In this work, we propose the creation of the Amazon Biobank, a community-based genetic database. We employed blockchain to build a transparent and verifiable log of transactions involving genomic data, and we used smart contracts to implement an internal monetary system for all participants who collect, insert, process, store, and validate genomic data. We also used peer-to-peer solutions to allow users with commodity computers to collaborate with the storage and distribution of DNA files. By combining emerging technologies, Amazon Biobank provides adequate benefit-sharing among all participants that collaborate with data, knowledge, and computational resources. It also provides traceability and auditability, allowing easy association between biotechnological research and DNA data. In addition, the solution is highly scalable and less dependent on the trust deposited in any system player. Therefore, Amazon Biobank can become an important stepping stone to unlock the potential of bioeconomy in rich ecosystems such as the Amazon Rainforest.

Indexed as

Biological Specimen BanksEcosystemDatabases, GeneticDNAGenomicsHumansDNAAmazon Sustainable DevelopmentBenefit-sharingBiodiversityBlockchainDNA databaseDNA sequencing

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.